Manufacturer of Controlled Substances; Notice of Registration, 70985 [E6-20690]
Download as PDF
<![CDATA[
70985
Federal Register / Vol. 71, No. 235 / Thursday, December 7, 2006 / Notices
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
Manufacturer of Controlled
Substances; Notice of Application
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated August 15, 2006 and
published in the Federal Register on
August 22, 2006, (71 FR 48945),
Applied Science Labs, Division of
Alltech Associates Inc., 2701 Carolean
Industrial Drive, State College,
Pennsylvania 16801, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the basic classes of
controlled substances listed in schedule
I and II:
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on August 24, 2006,
Cayman Chemical Company, 1180 East
Ellsworth Road, Ann Arbor, Michigan
48108, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in schedule
I:
By Notice dated June 9, 2006, and
published in the Federal Register on
June 19, 2006, (71 FR 35310—35311),
Cedarburg Pharmaceuticals, Inc., 870
Badger Circle, Grafton, Wisconsin
53024, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
schedules I and II:
Drug
Heroin (9200) ................................
Cocaine (9041) .............................
Codeine (9050) .............................
Meperidine (9230) .........................
Methadone (9250) ........................
Morphine (9300) ...........................
Marihuana (7360) ..............................
Tetrahydrocannabinols (7370) ..........
I
II
II
II
II
II
The company plans to import these
controlled substances for the
manufacture of reference standards.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Applied Science Labs to import the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated Applied
Science Labs to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
sroberts on PROD1PC70 with NOTICES
Schedule
Drug
Schedule
Dated: November 28, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–20747 Filed 12–6–06; 8:45 am]
I
I
The company plans to manufacture
small quantities of marihuana
derivatives for research purposes. In
reference to drug code 7360
(Marihuana), the company plans to bulk
manufacture cannabidiol. In reference to
drug code 7370
(Tetrahydrocannabinols), the company
will manufacture a synthetic THC. No
other activity for this drug code is
authorized for registration.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such substances
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative/ODL; or
any being sent via express mail should
be sent to DEA Headquarters, Attention:
DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than February 5, 2007.
Dated: November 28, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–20694 Filed 12–6–06; 8:45 am]
BILLING CODE 4410–09–P
Drug
Tetrahydrocannabinols (7370) .....
Dihydromorphine (9145) ...............
Oxycodone (9143) ........................
Hydrocodone (9193) .....................
Hydromorphone (9150) ................
18:18 Dec 06, 2006
Jkt 211001
PO 00000
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Cedarburg Pharmaceuticals, Inc. to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Cedarburg Pharmaceuticals,
Inc. to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with State
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: November 28, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–20690 Filed 12–6–06; 8:45 am]
BILLING CODE 4410–09–P
Frm 00040
Fmt 4703
Sfmt 4703
I
I
II
II
II
The firm plans to manufacture the
listed controlled substances in bulk for
distribution to its customers. By letter
dated September 5, 2006, the company
has withdrawn their request for the
addition of Methylphenidate (1724), to
their application for registration.
BILLING CODE 4410–09–P
VerDate Aug<31>2005
Schedule
E:\FR\FM\07DEN1.SGM
07DEN1
]]>Agencies
[Federal Register Volume 71, Number 235 (Thursday, December 7, 2006)]
[Notices]
[Page 70985]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-20690]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated June 9, 2006, and published in the Federal Register
on June 19, 2006, (71 FR 35310--35311), Cedarburg Pharmaceuticals,
Inc., 870 Badger Circle, Grafton, Wisconsin 53024, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as a bulk manufacturer of the basic classes of controlled substances
listed in schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)............... I
Dihydromorphine (9145)..................... I
Oxycodone (9143)........................... II
Hydrocodone (9193)......................... II
Hydromorphone (9150)....................... II
------------------------------------------------------------------------
The firm plans to manufacture the listed controlled substances in
bulk for distribution to its customers. By letter dated September 5,
2006, the company has withdrawn their request for the addition of
Methylphenidate (1724), to their application for registration.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Cedarburg Pharmaceuticals, Inc. to manufacture the listed basic classes
of controlled substances is consistent with the public interest at this
time. DEA has investigated Cedarburg Pharmaceuticals, Inc. to ensure
that the company's registration is consistent with the public interest.
The investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with State and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: November 28, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-20690 Filed 12-6-06; 8:45 am]
BILLING CODE 4410-09-P
